Beijing Balance Medical Technology Co Ltd
Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patch… Read more
Beijing Balance Medical Technology Co Ltd (688198) - Total Assets
Latest total assets as of June 2025: CN¥1.45 Billion CNY
Based on the latest financial reports, Beijing Balance Medical Technology Co Ltd (688198) holds total assets worth CN¥1.45 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Beijing Balance Medical Technology Co Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Beijing Balance Medical Technology Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Beijing Balance Medical Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Beijing Balance Medical Technology Co Ltd's total assets of CN¥1.45 Billion consist of 41.3% current assets and 58.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 3.9% |
| Accounts Receivable | CN¥121.56 Million | 8.5% |
| Inventory | CN¥52.74 Million | 3.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥112.18 Million | 7.8% |
| Goodwill | CN¥17.27 Million | 1.2% |
Asset Composition Trend (2016–2024)
This chart illustrates how Beijing Balance Medical Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Beijing Balance Medical Technology Co Ltd's current assets represent 41.3% of total assets in 2024, a decrease from 43.8% in 2016.
- Cash Position: Cash and equivalents constituted 3.9% of total assets in 2024, down from 38.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 13.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 8.5% of total assets.
Beijing Balance Medical Technology Co Ltd Competitors by Total Assets
Key competitors of Beijing Balance Medical Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Beijing Balance Medical Technology Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Beijing Balance Medical Technology Co Ltd generates 0.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Beijing Balance Medical Technology Co Ltd generates $ 10.23 in net profit.
Beijing Balance Medical Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.32 | 5.71 | 38.61 |
| Quick Ratio | 2.91 | 5.22 | 37.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥386.29 Million | CN¥ 397.53 Million | CN¥ 749.50 Million |
Beijing Balance Medical Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Beijing Balance Medical Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.22 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | 7.8% |
| Total Assets | CN¥1.43 Billion |
| Market Capitalization | $625.31 Million USD |
Valuation Analysis
Below Book Valuation: The market values Beijing Balance Medical Technology Co Ltd's assets below their book value (0.44 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Beijing Balance Medical Technology Co Ltd's assets grew by 7.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Beijing Balance Medical Technology Co Ltd (2016–2024)
The table below shows the annual total assets of Beijing Balance Medical Technology Co Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.43 Billion | +7.82% |
| 2023-12-31 | CN¥1.33 Billion | +12.49% |
| 2022-12-31 | CN¥1.18 Billion | +14.42% |
| 2021-12-31 | CN¥1.03 Billion | +18.31% |
| 2020-12-31 | CN¥871.44 Million | +10.55% |
| 2019-12-31 | CN¥788.29 Million | +275.29% |
| 2018-12-31 | CN¥210.05 Million | +43.25% |
| 2017-12-31 | CN¥146.63 Million | +18.71% |
| 2016-12-31 | CN¥123.52 Million | -- |